In an ongoing effort to curb rising health care costs, the Federal Trade Commission (FTC) continues to meet its commitment to enforce regulatory action against health care consolidation and associated price increases. Under the guidance of Chair Khan, the FTC’s approach has closely aligned with President Biden’s initiative to control and reduce healthcare expenses.
The FTC’s dedication to this cause is evident in its actions over the last two years where it has utilized innovative competitive measures. An example of this commitment became apparent last week when the FTC filed a lawsuit against a private equity firm and its corresponding specialty practice. It accused them of violations suggesting a tangible follow-through on its pledge, detailed in a report by JD Supra.
This unprecedented tactic demonstrates the FTC’s readiness to target any actions that might contribute to healthcare cost escalation, even if they come from non-traditional sources such as private equity firms. As such, the lawsuit sends a significant message to parties both inside and outside the health sector.
On the heels of this bold move, many legal professionals and organizations will follow closely as it might signify a shift in how the FTC will handle competition law violations moving forward. The broader implications could potentially affect legal strategies, especially for law firms and corporations dealing with health care and competition law. Thus, keeping abreast with the FTC’s strategies remains crucial for law firms and corporations as they navigate this rapidly shifting landscape.